Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;36(6):583-9.
doi: 10.3343/alm.2016.36.6.583.

Relationship Between Cytogenetic Complexity and Peritumoral Edema in High-Grade Astrocytoma

Affiliations

Relationship Between Cytogenetic Complexity and Peritumoral Edema in High-Grade Astrocytoma

Kyung Ho Jeong et al. Ann Lab Med. 2016 Nov.

Abstract

Background: The purpose of the study is to reveal the association of cytogenetic compltyexi and peritumoral edema volume (PTEV) and its prognostic significance in high-grade astrocytoma patients by culturing patient tumor cells.

Methods: Twenty-seven high-grade astrocytoma patients were divided into three groups according to karyotype complexity: normal, non-complex karyotype (NCK), and complex karyotype (CK). Endothelial growth factor receptor (EGFR) amplification was detected by FISH, and its association with chromosome 7 abnormalities was analyzed. Mean PTEV of each group was compared by ANOVA to evaluate the relationship between PTEV and cytogenetic complexity.

Results: The PTEV of patients in normal (n=6), NCK (n=8), and CK (n=13) groups were 24.52±17.73, 34.26±35.04, and 86.31±48.7 cm³, respectively (P=0.005). Ten out of 11 patients with EGFR amplification showed abnormalities in chromosome 7. The mean PTEV of EGFR-amplified and non-amplified groups were 80.4±53.7 and 41.3±37.9 cm³, respectively (P=0.035). The average survival of patients with PTEV less than 90 cm³ was 30.52±26.11 months, while in patients with PTEVs over or equal to 90 cm³, it was 10.83±5.53 months (P=0.007).

Conclusions: The results show an association of complex karyotype with the PTEV of high-grade astrocytoma. EGFR amplification plays a significant role in the formation of peritumoral edema, causing PTEV to increase, which is related with survival. This implies that cytogenetic karyotype can be applied as a prognostic factor.

Keywords: Chromosome; EGFR amplification; High-grade astrocytoma; Peritumoral edema.

PubMed Disclaimer

Conflict of interest statement

Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.

Figures

Fig. 1
Fig. 1. Kaplan-Meier Survival curve of patients with peritumoral edemas less than 90 cm3 and patients with peritumoral edema of 90 cm3 or greater, as analyzed by the log-rank test.
Fig. 2
Fig. 2. T2 FLAIR image (A) and T1 gadolinium-enhanced magnetic resonance imaging (MRI) image (B) of a 55-yr-old anaplastic astrocytoma patient with a normal female chromosome (C) and without EGFR amplification. There is minimal high signal around the tumor mass. The survival of the patient was 110 months.
Fig. 3
Fig. 3. T1 gadolinium-enhanced magnetic resonance imaging (MRI) image (A) and T2 FLAIR image (B) of a 66-yr-old glioblastoma multiforme patient with complex karyotype (C) and positive EGFR amplification. A large amount of peritumoral edema with a midline shift was confirmed by T2 FLAIR image. 50,XY, dic(1;4)(p1 3;q35),+5,+7,+7,add(6p),del(7)(p15),add(9)(p24),add(17)(q25) add(19)(q13.4), add(21)(p13),+mar[20]. The survival of the patient was 9 months.

Similar articles

Cited by

References

    1. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64:479–489. - PubMed
    1. Heimberger AB, Hlatky R, Suki D, Yang D, Weinberg J, Gilbert M, et al. Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. Clin Cancer Res. 2005;11:1462–1466. - PubMed
    1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996. - PubMed
    1. Walid MS. Prognostic factors for long-term survival after glioblastoma. Perm J. 2008;12:45–48. - PMC - PubMed
    1. Barker FG, 2nd, Simmons ML, Chang SM, Prados MD, Larson DA, Sneed PK, et al. EGFR overexpression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2001;51:410–418. - PubMed

MeSH terms

Substances